Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.5 (EPT/RI)-Alliance Pharma plc

13 Jan 2025 09:02

Form 8.5 (EPT/RI)-Alliance Pharma plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAlliance Pharma plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund)
(d) Date dealing undertaken:10th January 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesPurchases3,631,97261.260.8
Ordinary sharesSales3,679,32061.361

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th January 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91 9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
23rd May 20243:09 pmRNSSuccessful appeal of CMA decision
22nd May 20247:00 amRNSNotification of Major Interest in Shares
15th May 20249:14 amRNSNotification of Major Holdings
8th May 20247:00 amRNSFurther Update on Preliminary Results
8th May 20247:00 amRNSManagement Update
26th Apr 20247:00 amRNSPreliminary Results Publication Date
22nd Apr 20247:00 amRNSFurther update on timing of preliminary results
5th Apr 20247:00 amRNSUpdate on Timing of Preliminary Results
2nd Apr 202411:12 amRNSTotal Voting Rights
4th Mar 20248:00 amRNSTotal Voting Rights
4th Mar 20247:00 amRNSNotification of Full Year Results
5th Feb 20247:00 amRNSNew Chair Appointment
29th Jan 20247:00 amRNSFull Year Trading Update
2nd Jan 202410:51 amRNSBlock Listing Six Monthly Return
1st Dec 202312:23 pmRNSTotal Voting Rights
9th Nov 202311:17 amRNSNotification of Major Holdings
7th Nov 20237:00 amRNSAppointment of Non-Executive Directors
1st Nov 202312:50 pmRNSTotal Voting Rights
16th Oct 20236:13 pmRNSDirector Dealings
12th Oct 20232:51 pmRNSNotification of Major Interest in Shares
5th Oct 20234:39 pmRNSGrant of Options to Directors
2nd Oct 20233:14 pmRNSTotal Voting Rights
26th Sep 20237:00 amRNSInterim Results
22nd Sep 20235:28 pmRNSNotification of Major Holdings
4th Sep 20231:19 pmRNSNotification of Major Holdings
30th Aug 20234:29 pmRNSNotification of Major Holdings
29th Aug 202311:32 amRNSNotification of Major Holdings
15th Aug 20231:55 pmRNSNotification of Major Holdings
10th Aug 20237:00 amRNSNotification of Half Year Results
20th Jul 20239:54 amRNSDirector Dealing
19th Jul 20237:00 amRNSDirector Dealings
18th Jul 20237:00 amRNSHalf Year Trading Update
3rd Jul 20233:05 pmRNSTotal Voting Rights
29th Jun 20237:00 amRNSBlock Listing Six Monthly Return
1st Jun 20235:16 pmRNSTotal Voting Rights
25th May 202312:44 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
3rd May 202312:25 pmRNSTotal Voting Rights
3rd May 202312:08 pmRNSNotification of Major Holdings
12th Apr 202310:00 amRNSAnnual Report and Notice of AGM
5th Apr 202311:00 amRNSNotification of Major Holdings
4th Apr 202310:46 amRNSNotification of Major Holdings
3rd Apr 202310:04 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSNotification of Major Holdings
29th Mar 20237:00 amRNSNotification of Major Holdings
21st Mar 20234:59 pmRNSNotification of Major Holdings
21st Mar 20237:00 amRNSPreliminary Results
14th Mar 20231:47 pmRNSNotification of Major Holdings
7th Mar 202312:51 pmRNSNotification of Major Holdings
23rd Feb 20237:00 amRNSNotification of Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.